Rheumatoid arthritis predominantly affects women between the ages of 30 and 50, but it can occur in individuals of any age and gender. Approximately 30 to 60 million people worldwide are affected.

Yes, there are generally no contraindications for using Mesenchymal Stem Cell therapy in rheumatoid arthritis patients. However, a prior medical assessment is essential.

Lupus is known as the "great imitator" because it can affect any organ and mimic nearly any symptom. Common signs include butterfly-shaped facial rash, oral ulcers, muscle and joint pain, fatigue, depression, fever, hair loss, kidney and heart problems, among others. The intensity of symptoms varies greatly among individuals.

Yes, patients with lupus are excellent candidates for MSC therapy. When combined with a multidisciplinary approach, this therapy can delay disease progression, prevent complications, and enhance the effectiveness of conventional treatments.

The classic triad of symptoms includes increased appetite, thirst, and urination. Type 1 diabetes often presents severe symptoms at an early age, while Type 2 diabetes symptoms may develop gradually and include fatigue, blurred vision, and slow-healing sores.

MSC therapy offers a novel approach to treating diabetes by regenerating damaged beta cells, improving insulin sensitivity, and enhancing vascular permeability. This helps reduce symptoms and complications, significantly improving the patient's quality of life. However, an assessment by our doctors is necessary to establish a personalized treatment plan based on individual needs.

Symptoms vary widely but include lack of empathy, difficulty with verbal and non-verbal communication, repetitive behaviors, limited interests, and avoiding eye contact. Other signs are mood swings, focusing on parts of objects, and repeating words or phrases.

Yes, MSC therapy can help by regenerating damaged cells, improving the body's defense and metabolism systems, and stimulating substances that compensate for deficits in altered cells. This can reduce aggressive behavior, hyperactivity, and improve motor skills, attention, communication, and sleep patterns.

Symptoms include memory loss, language problems, difficulty performing simple tasks, disorientation, poor judgment, mood changes, and loss of initiative.

Yes, MSC therapy can delay disease progression, promote brain regeneration, regulate inflammation, and enhance brain plasticity and vascular permeability, improving the quality of life for patients.

Symptoms include sudden numbness or weakness in the face, arms, or legs, confusion and language difficulties, sudden headaches, trouble walking or standing, incoordination, and dizziness.

Yes, MSC therapy can accelerate recovery by promoting the creation of new blood vessels, regulating inflammation, and enhancing cell survival and proliferation. This therapy, combined with conventional treatments, improves functionality and quality of life, aiding in the return to daily activities.

Symptoms include shortness of breath, especially during exercise, persistent dry cough, rapid and shallow breathing, gradual weight loss, tiredness, joint and muscle pain, and clubbing of the fingertips.

Yes, MSC therapy is an excellent option for these patients. It slows disease progression, increases tissue plasticity, and improves symptoms, potentially enhancing life expectancy. However, a medical assessment is necessary to determine the appropriate treatment protocol.

Hypertension often has no specific symptoms and can be diagnosed casually. However, non-specific symptoms can include headaches, difficulty breathing, nosebleeds, restlessness, nervousness, palpitations, and tremors.

Yes, MSC therapy can improve arterial elasticity, create new blood vessels, and reduce the heart's workload. This helps achieve better blood pressure levels, reduces the risk of myocardial infarctions, and minimizes long-term complications.

Symptoms include slowness of movement, tremor at rest, muscle stiffness, postural instability, shuffling gait, sleep and mood disturbances, constipation, and loss of smell.

Yes, MSC therapy can delay disease progression, promote nervous system regeneration, improve neuronal connections, and strengthen affected muscles, thereby reducing symptoms and enhancing quality of life.

Symptoms include cyclical eruptions of erythematous plaques on the trunk, scalp, elbows, and knees, which are often itchy and swollen. Large joints may also experience pain, particularly during stress periods.

Yes, MSC therapy can be an excellent adjuvant treatment for psoriasis. It targets the skin, offering immunomodulatory effects, skin cell regeneration, and powerful anti-inflammatory benefits, improving overall skin health and patient quality of life.

Symptoms include joint pain, functional limitation, stiffness, inflammation, and weakness. These symptoms can significantly impact mobility and quality of life.

MSC therapy is a non-surgical, non-pharmacological treatment that promotes tissue repair and regeneration by differentiating into bone, cartilage, and tendons. It can relieve symptoms, slow the disease’s progression, and may even prevent the need for prosthetic surgery in some cases.